Lonza Capsules & Health Ingredients
Supplier of undenatured collagen and capsule formats such as HPMC, pullulan and capsule-in-capsule.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Lonza Capsules & Health Ingredients (CHI) is a division of Lonza Group AG (SIX: LONN), a Swiss multinational with major US operations. The division combines branded health ingredients with advanced capsule delivery technologies. Their flagship ingredient UC-II (undenatured type II collagen) is backed by 20+ studies and supports joint health at a low 40mg/day dose; it received FDA NDI notification. Lonza's capsule portfolio includes Capsugel Vcaps Plus (HPMC), Plantcaps (pullulan), and Licaps (liquid-filled hard capsules). Their Duocap technology enables capsule-in-capsule formats for combining incompatible ingredients. Lonza also offers concept-to-market services connecting ingredient partners with supplement brands. The company manufactures UC-II at an FDA-registered US facility.
Certifications
1 of 3 certifications independently confirmed. What this means
INGREDIENT REGULATORY STATUS
- NDI-Notified IngredientsNew dietary ingredient notification filed with FDA: Zinc carnosine (NDIN 158 (2002)) · source
Capabilities
- PRODUCT TYPES
- UC-II Collagen · HPMC Capsules (Vcaps Plus) · Pullulan Capsules (Plantcaps) · Liquid-Filled Capsules (Licaps) · Capsule-in-Capsule (Duocap)
- CAPABILITIES
- Branded or patented ingredients · Clinical research or study support · Collagen, proteins or peptides · Delivery or absorption technology · Custom development or formulation help
Sources
- Lonza - Nutraceutical Solutions(2026-03-26)
- Lonza - UC-II Collagen Ingredient(2026-03-26)
- NutritionInsight - Lonza Capsugel at CPHI 2025(2026-03-26)
- FSSC 22000 Public Register — Lonza Greenwood, LLC (Greenwood, SC)(2026-07-09)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Division of a large multinational; may not serve small-volume supplement startups
- Specific US facility locations not publicly disclosed on Capsugel website
- FDA Registered and cGMP compliance are self-reported; FSSC 22000 is registry-confirmed via the FSSC public register (fssc.com)
- Mid-divestiture: Lonza Group AG announced Q1 2026 sale of Capsules & Health Ingredients division to Lone Star Funds for ~$3B enterprise value. Closing expected H2 2026. Lonza retains 40% stake post-closing per public filings (Source: Nutraceutical Business Review, NutraIngredients Q1 2026 M&A roundup). Vendor status to be reassessed post-closing.
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
Disclosures
- Lonza CHI is a division of Lonza Group AG (SIX: LONN), a Swiss multinational
The connection map between Lonza Capsules & Health Ingredients and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Interested in Lonza Capsules & Health Ingredients?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.